�A new Mayo Clinic study shows that variations in the serotonin transporter gene could explain wherefore some people with depressive disorder respond better than others to treatment with citalopram (Celexa), an antidepressant medication.
The study, in the stream issue of the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, examined the serotonin
